Frontier-tech focused venture capital firm Bluehill.VC has announced the final close of its maiden fund at ₹400 crore, including the subscription of a ₹50-crore greenshoe option, as investor interest grows in India’s emerging deep-tech and strategic technology ecosystem.
The fund has attracted participation from institutional investors including SIDBI and the governments of Kerala and Uttar Pradesh, along with leading family offices, entrepreneurs and ultra-high-net-worth individuals (UHNIs) from India and the West Asia.
Bluehill.VC said the fund received interest from a broader pool of institutional and HNI investors than could be accommodated within its targeted closing timeline. While the firm could not accommodate all commitments in the maiden fund, it plans to engage with these investors for its next fund, targeted for 2027.
Betting on India’s frontier-tech opportunity
The successful fund close comes amid growing investor interest in India’s frontier-technology opportunity, with geopolitical priorities, industrial policy and advances in science and engineering reshaping global innovation.
Bluehill.VC said India is producing a new generation of companies developing technologies with both commercial potential and strategic importance.
Bluehill.VC, Managing Partner & Co-founder, Manu Iyer, said the next wave of enduring value creation would increasingly come from companies solving complex engineering and scientific problems.
“India today has the talent, policy momentum and entrepreneurial ambition to build globally competitive businesses across defence, semiconductors, space, energy and advanced manufacturing,” he said.
Iyer said the fund’s final close was a strong endorsement of the firm’s investment thesis and investor confidence in its ability to identify exceptional founders early and support them over the long term.
“Our ambition is simple, to help build companies from India that don’t just participate in global markets, but define them,” he added.
Seed to Series A focus
Bluehill.VC invests from Seed to Series A in startups developing proprietary technologies across areas including energy, EVs, nuclear, semiconductors, advanced materials, defence, space, water, manufacturing, robotics, industrial technologies and IoT.
The fund plans to build a concentrated portfolio of 15-16 companies, with an average initial institutional investment of up to $1-2 million.
The firm follows an “invest-and-build” approach, working closely with founders as they develop their technologies and businesses.
Since beginning investments, Bluehill.VC has already deployed more than ₹100 crore across seven portfolio companies.
Deep-tech founders beyond traditional hubs
Bluehill.VC, Managing Partner & Co-founder, Sridhar Parthasarathy, said frontier-tech investing requires deeper technical understanding and greater conviction because such businesses often take longer to develop.
“These companies take longer to build, demand deeper technical understanding and solve problems that few others are willing to tackle. But when they succeed, they create technologies that are difficult to replicate, globally competitive and capable of defining entire industries,” he said.
Parthasarathy said Bluehill.VC is focused on founders developing technologies from first principles and pursuing genuine technological breakthroughs rather than incremental improvements.
He added that the firm’s search for frontier-tech founders extends beyond premier educational institutions to research laboratories, manufacturing clusters, defence programmes and universities across India.
₹80 crore deployment planned
Bluehill.VC has built an active investment pipeline and plans to deploy approximately ₹80 crore over the next six months.
The firm intends to continue backing founders developing breakthrough technologies with strategic relevance and global commercial potential.
Its existing portfolio includes EtherealX, which is developing reusable launch systems for space transportation; Zebu Intelligent Systems, a counter-drone technology company that has won three iDEX challenges and works with the Indian Armed Forces; Helex, which is developing therapeutics for genetic kidney diseases; Sophrosyne Technologies, a fabless semiconductor company developing biosensing SoCs for wearable and digital health applications; and optoML, which is developing an Analog AI System-on-Chip platform based on FinFET technology and integrated optical interconnects.
The fund’s closure and planned deployment underline Bluehill.VC’s strategy of backing Indian founders working on technically complex technologies with the potential to compete in global markets.
With ₹80 crore earmarked for deployment over the next six months and a portfolio already spanning space, defence, semiconductors, healthcare and AI, the venture capital firm is positioning itself as a specialist investor in India’s emerging frontier-tech ecosystem.